CovidChloroV1, Main, Corpus, bibRecord, 001417

Pharmacist's perspective on HCQ treatment of COVID-19.

Identifieur interne : 001417 ( Main/Corpus ); précédent : 001416; suivant : 001418

Pharmacist's perspective on HCQ treatment of COVID-19.

Auteurs : Ya-Ling Wang ; Shih-Han Wang ; Ai-Yu Yang

Source :

The Kaohsiung journal of medical sciences [ 2410-8650 ] ; 2020.

RBID : pubmed:32533592

English descriptors

KwdEn :
- Azithromycin (MeSH), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Humans (MeSH), Hydroxychloroquine (MeSH), Pandemics (MeSH), Pharmacists (MeSH), Pneumonia, Viral (MeSH), SARS-CoV-2 (MeSH).
MESH :
- chemical : Azithromycin, Hydroxychloroquine.
- drug therapy : Coronavirus Infections.
- Betacoronavirus, COVID-19, Humans, Pandemics, Pharmacists, Pneumonia, Viral, SARS-CoV-2.

DOI: 10.1002/kjm2.12249
PubMed: 32533592
PubMed Central: PMC7323069

Links to Exploration step

pubmed:32533592

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacist's perspective on HCQ treatment of COVID-19.</title>
<author><name sortKey="Wang, Ya Ling" sort="Wang, Ya Ling" uniqKey="Wang Y" first="Ya-Ling" last="Wang">Ya-Ling Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Shih Han" sort="Wang, Shih Han" uniqKey="Wang S" first="Shih-Han" last="Wang">Shih-Han Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Ai Yu" sort="Yang, Ai Yu" uniqKey="Yang A" first="Ai-Yu" last="Yang">Ai-Yu Yang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32533592</idno>
<idno type="pmid">32533592</idno>
<idno type="doi">10.1002/kjm2.12249</idno>
<idno type="pmc">PMC7323069</idno>
<idno type="wicri:Area/Main/Corpus">001417</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001417</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pharmacist's perspective on HCQ treatment of COVID-19.</title>
<author><name sortKey="Wang, Ya Ling" sort="Wang, Ya Ling" uniqKey="Wang Y" first="Ya-Ling" last="Wang">Ya-Ling Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Shih Han" sort="Wang, Shih Han" uniqKey="Wang S" first="Shih-Han" last="Wang">Shih-Han Wang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Ai Yu" sort="Yang, Ai Yu" uniqKey="Yang A" first="Ai-Yu" last="Yang">Ai-Yu Yang</name>
<affiliation><nlm:affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The Kaohsiung journal of medical sciences</title>
<idno type="eISSN">2410-8650</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pharmacists (MeSH)</term>
<term>Pneumonia, Viral (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Azithromycin</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pharmacists</term>
<term>Pneumonia, Viral</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32533592</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2410-8650</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>36</Volume>
<Issue>8</Issue>
<PubDate><Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>The Kaohsiung journal of medical sciences</Title>
<ISOAbbreviation>Kaohsiung J Med Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Pharmacist's perspective on HCQ treatment of COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>660</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/kjm2.12249</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Ya-Ling</ForeName>
<Initials>YL</Initials>
<Identifier Source="ORCID">0000-0001-9389-5234</Identifier>
<AffiliationInfo><Affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Shih-Han</ForeName>
<Initials>SH</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Ai-Yu</ForeName>
<Initials>AY</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>China (Republic : 1949- )</Country>
<MedlineTA>Kaohsiung J Med Sci</MedlineTA>
<NlmUniqueID>100960562</NlmUniqueID>
<ISSNLinking>1607-551X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Int J Antimicrob Agents. 2020 Jul;56(1):105949</RefSource>
<PMID Version="1">32205204</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="Y">Azithromycin</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010595" MajorTopicYN="Y">Pharmacists</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32533592</ArticleId>
<ArticleId IdType="doi">10.1002/kjm2.12249</ArticleId>
<ArticleId IdType="pmc">PMC7323069</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2020 Jun;50(4):384</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Toxicol Appl Pharmacol. 1967 May;10(3):501-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6059665</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001417 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001417 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32533592
   |texte=   Pharmacist's perspective on HCQ treatment of COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32533592" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Pharmacist's perspective on HCQ treatment of COVID-19.

Pharmacist's perspective on HCQ treatment of COVID-19.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki